Showing 1 - 8 results of 8 for search 'Fabio Monari', query time: 0.03s Refine Results
  1. 1
    Cost-effectiveness profile, organizational implications and patient preferences on the use of exogenous TSH therapy (Thyrogen®) vs. THW in thyroid residue ablation in Italy

    Cost-effectiveness profile, organizational implications and patient preferences on the use of exogenous TSH therapy (Thyrogen®) vs. THW in thyroid residue ablation in Italy by Gianluca De Danieli, Fabio Monari, Renzo Lazzarini, Filippo Cipriani

    Published 2016-10-01
    Get full text
    Article
  2. 2
    Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC)

    Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC) by Elisa Lodi Rizzini, Andrea Repaci, Elena Tabacchi, Lucia Zanoni, Valentina Vicennati, Ottavio Cavicchi, Uberto Pagotto, Alessio Giuseppe Morganti, Stefano Fanti, Fabio Monari

    Published 2021-08-01
    Get full text
    Article
  3. 3
    Usefulness of PET/CT with <sup>18</sup>F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study

    Usefulness of PET/CT with <sup>18</sup>F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study by Luca Filippi, Viviana Frantellizzi, Fabio Monari, Elisa Lodi Rizzini, Elena Tabacchi, Riccardo Pirisino, Andrea Marongiu, Susanna Nuvoli, Oreste Bagni, Giuseppe De Vincentis, Orazio Schillaci, Angela Spanu

    Published 2021-07-01
    Get full text
    Article
  4. 4
    Treatment of Advanced Gastro-Entero-Pancreatic Neuro-Endocrine Tumors: A Systematic Review and Network Meta-Analysis of Phase III Randomized Controlled Trials

    Treatment of Advanced Gastro-Entero-Pancreatic Neuro-Endocrine Tumors: A Systematic Review and Network Meta-Analysis of Phase III Randomized Controlled Trials by Claudio Ricci, Giuseppe Lamberti, Carlo Ingaldi, Cristina Mosconi, Nico Pagano, Laura Alberici, Valentina Ambrosini, Lisa Manuzzi, Fabio Monari, Deborah Malvi, Francesca Rosini, Francesco Minni, Davide Campana, Riccardo Casadei

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification

    Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification by Giovanni Tallini, Antonio De Leo, Andrea Repaci, Dario de Biase, Maria Letizia Bacchi Reggiani, Doriana Di Nanni, Francesca Ambrosi, Cira Di Gioia, Giorgio Grani, Kerry Jane Rhoden, Erica Solaroli, Fabio Monari, Sebastiano Filetti, Cosimo Durante

    Published 2020-01-01
    Get full text
    Article
  6. 6
    The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study

    The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study by Maria Silvia De Feo, Viviana Frantellizzi, Matteo Bauckneht, Alessio Farcomeni, Luca Filippi, Elisa Lodi Rizzini, Valentina Lavelli, Maria Lina Stazza, Tania Di Raimondo, Giuseppe Fornarini, Sara Elena Rebuzzi, Mammini Filippo, Paolo Mammucci, Andrea Marongiu, Fabio Monari, Giuseppe Rubini, Angela Spanu, Giuseppe De Vincentis

    Published 2023-04-01
    Get full text
    Article
  7. 7
    Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma

    Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma by Margherita Nannini, Margherita Nannini, Andrea Repaci, Gianluca Ricco, Manuela Ianni, Arber Golemi, Vincenzo Maiolo, Marco Ferrari, Filippo Natali, Elisa Lodi Rizzini, Fabio Monari, Erica Solaroli, Antonio De Leo, Antonio De Leo, Thais Maloberti, Maria A. Pantaleo, Maria A. Pantaleo, Dario De Biase, Dario De Biase, Giovanni Tallini, Giovanni Tallini

    Published 2022-12-01
    Get full text
    Article
  8. 8
    Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study

    Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Seconda... by Matteo Bauckneht, Sara Elena Rebuzzi, Marta Ponzano, Roberto Borea, Alessio Signori, Viviana Frantellizzi, Elisa Lodi Rizzini, Manlio Mascia, Valentina Lavelli, Alberto Miceli, Maria Silvia De Feo, Antonio Rosario Pisani, Susanna Nuvoli, Vincenzo Tripoli, Alessio Giuseppe Morganti, Paolo Mammucci, Salvatore Caponnetto, Guglielmo Mantica, Angelo Domenico Di Nicola, Carlo Villano, Luca Cindolo, Silvia Morbelli, Gianmario Sambuceti, Stefano Fanti, Renato Patrizio Costa, Angela Spanu, Giuseppe Rubini, Fabio Monari, Giuseppe De Vincentis, Giuseppe Fornarini

    Published 2022-03-01
    Get full text
    Article

Search Tools: